HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahmood Jeddi-Tehrani Selected Research

Insulin (Novolin)

2/2016Obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats.
4/2015Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahmood Jeddi-Tehrani Research Topics

Disease

43Neoplasms (Cancer)
06/2022 - 01/2007
18B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 02/2003
13Breast Neoplasms (Breast Cancer)
02/2020 - 04/2009
9Infections
01/2022 - 05/2014
8Tetanus
10/2021 - 06/2007
7Whooping Cough (Pertussis)
01/2018 - 06/2007
7Spontaneous Abortion (Miscarriage)
07/2017 - 04/2006
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2015 - 06/2005
6Carcinoma (Carcinomatosis)
12/2015 - 07/2009
5Hepatitis B
10/2021 - 09/2013
5Habitual Abortion (Recurrent Miscarriage)
10/2015 - 08/2010
4Testicular Neoplasms (Testicular Cancer)
01/2020 - 05/2014
4Leukemia
01/2014 - 02/2003
4Hematologic Neoplasms (Hematological Malignancy)
04/2013 - 01/2010
3COVID-19
01/2022 - 01/2021
3Colorectal Neoplasms (Colorectal Cancer)
05/2019 - 01/2004
3Infertility (Sterility)
01/2019 - 04/2006
3Ovarian Neoplasms (Ovarian Cancer)
08/2018 - 12/2009
3Endometriosis
09/2014 - 06/2008
3Diphtheria
06/2013 - 06/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2011 - 06/2005
2Spasm (Spasms)
10/2021 - 02/2020
2Cutaneous Leishmaniasis
01/2020 - 12/2017
2Prostatic Neoplasms (Prostate Cancer)
07/2019 - 01/2015
2Obesity
02/2016 - 10/2012
2Choroidal Neovascularization
10/2015 - 11/2013
2Brucellosis (Malta Fever)
11/2014 - 11/2014
2Communicable Diseases (Infectious Diseases)
01/2014 - 05/2009
2Thrombophilia
09/2010 - 04/2006
2Pathologic Processes
08/2010 - 01/2007
1Chronic Hepatitis B
10/2021
1Rubella (German Measles)
01/2021

Drug/Important Bio-Agent (IBA)

21Monoclonal AntibodiesIBA
01/2022 - 04/2009
21AntigensIBA
12/2021 - 02/2003
14Proteins (Proteins, Gene)FDA Link
06/2022 - 06/2005
14AntibodiesIBA
10/2021 - 06/2007
12VaccinesIBA
01/2021 - 02/2003
9Trastuzumab (Herceptin)FDA Link
01/2022 - 07/2013
9Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2018 - 01/2007
8EpitopesIBA
06/2022 - 02/2003
5CytokinesIBA
01/2019 - 06/2008
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017 - 09/2013
4Peptides (Polypeptides)IBA
01/2022 - 01/2014
4Immunoglobulins (Immunoglobulin)IBA
03/2020 - 10/2016
4Biological ProductsIBA
01/2019 - 03/2008
3EnzymesIBA
01/2022 - 01/2007
3LigandsIBA
10/2021 - 07/2014
3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 09/2010
3Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2015
3pertuzumabIBA
01/2021 - 01/2018
3tetanospasmin (tentoxilysin)IBA
02/2020 - 01/2014
3Prostate-Specific Antigen (Semenogelase)IBA
01/2019 - 12/2014
3Pharmaceutical PreparationsIBA
11/2018 - 01/2010
3sortilinIBA
12/2015 - 07/2009
3Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
10/2015 - 04/2006
3FibromodulinIBA
08/2013 - 06/2005
3Tumor Biomarkers (Tumor Markers)IBA
03/2013 - 07/2009
3Pertussis VaccineIBA
01/2013 - 06/2007
3Messenger RNA (mRNA)IBA
01/2013 - 02/2008
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2008 - 02/2003
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 09/2008
2ImmunosorbentsIBA
01/2022 - 01/2020
2Immunoglobulin G (IgG)IBA
12/2021 - 01/2021
2NeurotoxinsIBA
10/2021 - 03/2020
2hersintuzumabIBA
01/2021 - 01/2018
2Carcinoembryonic AntigenIBA
05/2019 - 01/2004
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2019 - 01/2004
2Docetaxel (Taxotere)FDA Link
11/2018 - 10/2017
2Fluorescein-5-isothiocyanate (FITC)IBA
08/2018 - 03/2013
2human ERBB2 proteinIBA
11/2017 - 01/2016
2hepatitis B hyperimmune globulinIBA
01/2017 - 10/2016
2Insulin (Novolin)FDA Link
02/2016 - 04/2015
2Hemagglutinins (Hemagglutinin)IBA
02/2016 - 02/2015
2Virulence Factors (Pathogenicity Factors)IBA
02/2016 - 02/2015
2ResveratrolIBA
10/2015 - 10/2013
2Retinaldehyde (Retinal)IBA
10/2015 - 11/2013
2Bevacizumab (Avastin)FDA Link
10/2015 - 11/2013
2Cholecalciferol (Vitamin D3)FDA Link
05/2015 - 09/2011
2Subunit VaccinesIBA
11/2014 - 11/2014
2Small Interfering RNA (siRNA)IBA
07/2014 - 01/2013
2Plasminogen Activator Inhibitor 1IBA
01/2014 - 11/2012
2IronIBA
10/2013 - 04/2009
2tyrosine receptor (receptor, tyrosine)IBA
04/2013 - 01/2007
2Phosphotransferases (Kinase)IBA
04/2013 - 01/2007
2factor V LeidenIBA
04/2012 - 04/2006
2Factor XIII (Coagulation Factor XIII)IBA
04/2012 - 09/2010
2HesperidinIBA
02/2012 - 01/2011
2hydroxide ionIBA
10/2011 - 09/2011
2FenretinideIBA
10/2011 - 01/2010
2Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA
06/2009 - 06/2007
1Tetanus ToxinIBA
06/2022
1Immunodominant EpitopesIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Immunoglobulin M (IgM)IBA
12/2021
1Pattern Recognition ReceptorsIBA
10/2021
1Poly I-CIBA
10/2021
1Interleukin-8 (Interleukin 8)IBA
10/2021

Therapy/Procedure

14Therapeutics
01/2022 - 09/2008
14Immunotherapy
01/2021 - 01/2007
2Quantum Dots (Quantum Dot)
08/2018 - 03/2013